| Literature DB >> 28572158 |
Douglas E Vaughan1, Rahul Rai2, Sadiya S Khan2, Mesut Eren2, Asish K Ghosh2.
Abstract
PAI-1 (plasminogen activator inhibitor-1) is a member of the evolutionarily conserved serine protease inhibitor family and a potent and rapid-acting inhibitor of both of the mammalian plasminogen activators. Organismal homeostasis requires physiological levels of endogenous PAI-1, and increased PAI-1 production guides the onset and progression of numerous human diseases and contributes to the multimorbidity of aging. Both chronological and stress-induced accelerated aging are associated with cellular senescence and accompanied by marked increases in PAI-1 expression in tissues. Recent studies suggest that PAI-1 is not only a marker but also a key mediator of cellular senescence and organismal aging. Here, we review the significance of PAI-1 as a bonafide marker, as well as a critical mediator, of cellular senescence associated with aging and aging-related pathologies.Entities:
Keywords: aging; arteriosclerosis; endothelial dysfunction; plasminogen activator inhibitor-1; thrombosis; transforming growth factor-β
Mesh:
Substances:
Year: 2017 PMID: 28572158 PMCID: PMC5846199 DOI: 10.1161/ATVBAHA.117.309451
Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN: 1079-5642 Impact factor: 8.311